Jane Street’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
53,200
+7,000
+15% +$638K ﹤0.01% 4117
2025
Q4
$6.01M Sell
46,200
-87,200
-65% -$12M ﹤0.01% 2963
2025
Q3
$14.4M Sell
133,400
-270,300
-67% -$29.4M ﹤0.01% 1984
2025
Q2
$37.3M Buy
403,700
+357,900
+781% +$28.1M 0.01% 955
2025
Q1
$4.06M Buy
45,800
+42,000
+1,105% +$3.64M ﹤0.01% 3243
2024
Q4
$292K Sell
3,800
-3,500
-48% -$244K ﹤0.01% 7778
2024
Q3
$310K Sell
7,300
-21,600
-75% -$730K ﹤0.01% 7974
2024
Q2
$755K Buy
+28,900
New +$548K ﹤0.01% 6311
2022
Q3
Sell
-388
Closed -$16K 10569
2022
Q2
$16K Sell
388
-1,370
-78% -$92.9K ﹤0.01% 9221
2022
Q1
$178K Sell
1,758
-4,075
-70% -$453K ﹤0.01% 9111
2021
Q4
$859K Sell
5,833
-6,537
-53% -$1.46M ﹤0.01% 6213
2021
Q3
$3.1M Buy
12,370
+7,482
+153% +$2.57M ﹤0.01% 3588
2021
Q2
$2.26M Buy
4,888
+3,936
+413% +$1.69M ﹤0.01% 4094
2021
Q1
$468K Buy
+952
New +$495K ﹤0.01% 6921

Other funds holding WGS

Jane Street's WGS Position: Q1 2026 in Review

Jane Street sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 29,625 shares — an estimated $2.7M sold.

Jane Street first reported a position in WGS in Q2 2021 and held it in 15 quarters. The position peaked at $9.94M in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Jane Street reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 29,625 GeneDx Holdings shares in Q1 2026, an estimated $2.7M.
  • Jane Street first reported a position in GeneDx Holdings in Q2 2021 and held it in 15 quarters.
  • Jane Street's GeneDx Holdings position peaked at $9.94M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.